Corbus Pharmaceuticals Holdings (CRBP) Net Cash Flow Growth (1y) (2014 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Net Cash Flow Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 198.34% |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 467.41% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -14,223.53% |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 453.08% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 135.08 Mn | 107.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 262.77% |
| Jun 30, 2025 | -88.06% |
| Mar 31, 2025 | 349.08% |
| Dec 31, 2024 | -189.90% |
| Sep 30, 2024 | -247.00% |
| Jun 30, 2024 | 835.59% |
| Mar 31, 2024 | 103.92% |
| Dec 31, 2023 | -45.71% |
| Sep 30, 2023 | 121.76% |
| Jun 30, 2023 | 103.28% |
| Mar 31, 2023 | -130.23% |
| Dec 31, 2022 | 137.64% |
| Sep 30, 2022 | -1,383.47% |
| Jun 30, 2022 | -1.21% |
| Mar 31, 2022 | 270.13% |
| Dec 31, 2021 | -439.96% |
| Sep 30, 2021 | -94.65% |
| Jun 30, 2021 | -283.27% |
| Mar 31, 2021 | -226.57% |
| Dec 31, 2020 | 115.42% |